Partners

Partners

Novavax has a number of active partnerships across the globe including a contract with the Bill & Melinda Gates Foundation, Biomedical Advanced Research and Development Authority (BARDA) to develop vaccines for seasonal and pandemic influenza valued at up to $179 million, as well as an ongoing collaboration with Cadila Pharmaceuticals and a partnership with LG Life Sciences.